Verastem (VSTM) Preferred Shares (2023 - 2024)
Verastem (VSTM) recorded quarterly Preferred Shares of $21.2 million in Q3 2024, little changed quarter-over-quarter from $21.2 million in Q2 2024, and little changed on a YoY basis from $21.2 million in Q4 2023.
Verastem (VSTM) Preferred Shares (2023 - 2024) Analysis & Trends
Verastem's Preferred Shares history runs 2 years deep, the most recent figure standing at $21.2 million for Q3 2024.
- In Q3 2024, Preferred Shares changed 0.0% year-over-year to $21.2 million; the TTM figure through Sep 2024 stood at $21.2 million (changed 0.0% YoY), while the FY2023 annual figure was $21.2 million, changed N/A from the prior year.
- Preferred Shares was $21.2 million for Q3 2024 at Verastem, roughly flat from $21.2 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $21.2 million in Q1 2023 to a low of $21.2 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 21.16 Mn |
| Jun 30, 2024 | 21.16 Mn |
| Mar 31, 2024 | 21.16 Mn |
| Dec 31, 2023 | 21.16 Mn |
| Sep 30, 2023 | 21.16 Mn |
| Jun 30, 2023 | 21.16 Mn |
| Mar 31, 2023 | 21.16 Mn |